Thrivent Financial for Lutherans’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$412K Buy
+1,662
New +$358K ﹤0.01% 2379
2023
Q3
Sell
-3,951
Closed -$605K 2457
2023
Q2
$605K Buy
3,951
+2,237
+131% +$349K ﹤0.01% 2105
2023
Q1
$266K Buy
+1,714
New +$269K ﹤0.01% 2316
2020
Q4
Hold
0
2406
2020
Q3
Hold
0
2275
2020
Q2
Hold
0
1589
2020
Q1
Hold
0
1388
2019
Q4
Hold
0
1602

Other funds holding FBT

Thrivent Financial for Lutherans's FBT Position: Q2 2026 in Review

Thrivent Financial for Lutherans opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 1,662 shares worth $412K. The stake represents ﹤0.01% of the portfolio and ranks #2379 among its holdings. This is a return to the name: Thrivent Financial for Lutherans previously reported a position in FBT as recently as Q2 2023.

Thrivent Financial for Lutherans first reported a position in FBT in Q1 2023 and has held it in 3 quarters since. The position peaked at $605K in Q2 2023. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Thrivent Financial for Lutherans held 1,662 shares of First Trust NYSE Arca Biotechnology Index Fund worth $412K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Thrivent Financial for Lutherans position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2379 holding.
  • Thrivent Financial for Lutherans first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and has held it in 3 quarters since.
  • Thrivent Financial for Lutherans's First Trust NYSE Arca Biotechnology Index Fund position peaked at $605K in Q2 2023.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.